Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Volume 60, Number 10, May 27, 2003
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abele, M.
Right arrow Articles by Klockgether, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abele, M.
Right arrow Articles by Klockgether, T.
Related Collections
Right arrow Autoimmune diseases
Right arrow Encephalitis
Right arrow Gastrointestinal
Right arrow Gait disorders/ataxia

Neurology 2003;60:1674-1675
© 2003 American Academy of Neurology


Brief Communications

Prevalence of antigliadin antibodies in ataxia patients

M. Abele, MD, L. Schöls, MD, S. Schwartz and T. Klockgether, MD

From the Departments of Neurology (Drs. Abele and Klockgether) and Pediatrics (S. Schwartz), University of Bonn, Germany; and Department of Neurology (Dr. Schöls), St. Josef Hospital, Bochum, Germany.

Address correspondence and reprint requests to Dr. T. Klockgether, MD, Department of Neurology, University of Bonn, Sigmund-Freud-Str. 25, D-53105 Bonn, Germany; e-mail: klockgether{at}uni-bonn.de

We determined antigliadin antibodies in 95 ataxia patients and 73 controls. Antibodies were positive in 8% of the controls, 19% of patients with sporadic ataxia, 8% of patients with recessive ataxia, and 15% of patients with dominant ataxia. Statistical comparison using {chi}2 statistics did not reveal significant differences between the groups. Although we found a trend toward a higher prevalence of antigliadin antibodies in patients with sporadic ataxia and dominant ataxia, our data do not support an association of ataxia with antigliadin antibodies.




Correspondence:

Read all Correspondence

Prevalence of antigliadin antibodies in ataxia patients
Khalaf Bushara, et al.
Neurology Online, 28 Oct 2003 [Full text]
Reply to Bushara and Hallett
Thomas Klockgether, et al.
Neurology Online, 28 Oct 2003 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by AAN Enterprises, Inc.